Broad-Spectrum Antiviral Agents: A Crucial Pandemic Tool

Amesh Adalja¹, Thomas Inglesby^{1

2}

Affiliations

¹ a Center for Health Security , Johns Hopkins Bloomberg School of Public Health , Baltimore , MD , USA.
² b Department of Environmental Health and Engineering , Johns Hopkins Bloomberg School of Public Health , Baltimore , MD , USA.

Editorial

Amesh Adalja et al. Expert Rev Anti Infect Ther. 2019 Jul.

. 2019 Jul;17(7):467-470.

doi: 10.1080/14787210.2019.1635009. Epub 2019 Jun 24.

Amesh Adalja¹, Thomas Inglesby^{1

2}

¹ a Center for Health Security , Johns Hopkins Bloomberg School of Public Health , Baltimore , MD , USA.
² b Department of Environmental Health and Engineering , Johns Hopkins Bloomberg School of Public Health , Baltimore , MD , USA.

No abstract available

Keywords: Antiviral; biosecurity; broad-spectrum; epidemic; pandemic.

References

1. Center for Health Security The characteristics of pandemic pathogens. cited March 4, 2019. Available from: http://www.centerforhealthsecurity.org/our-work/pubs_archive/pubs-pdfs/2....
1. Whitley RJ, Gnann JJ.. Acyclovir: a decade later. N Engl J Med. 1992;327:782–789. - PubMed
1. Goldner T, Hewlett G, Ettischer N, et al. The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase. J Virol. 2011;85:10884–10893. - PMC - PubMed
1. Poveda E, Briz V, Soriano V. Enfuviritide, the first inhibitor to treat HIV infection. AIDS Rev. 2005;7:139–147. - PubMed
1. Clark DN, Hu J. Hepatitis B virus reverse transcriptase-target of current antiviral therapy and future drug development. Antiviral Res. 2015;123:132–137. - PMC - PubMed